Placenta
Volume 30, Issue 6 , Pages 483-490 , June 2009

Placental Urocortins and CRF in Late Gestation

  • P.P.L.M. Pepels

      Affiliations

    • Department of Chemical Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, Geert Grooteplein 8, NL-6500 HB Nijmegen, The Netherlands
    • Department of Obstetrics & Gynaecology, Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands
    • Department of Endocrinology, Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands
    • ,
  • M.E.A. Spaanderman

      Affiliations

    • Department of Obstetrics & Gynaecology, Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands
    • ,
  • J. Bulten

      Affiliations

    • Department of Pathology, Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands
    • ,
  • P.B.A.M. Smits

      Affiliations

    • Department of Pharmacology and Toxicology, Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands
    • ,
  • A.R.M.M. Hermus

      Affiliations

    • Department of Endocrinology, Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands
    • ,
  • F.K. Lotgering

      Affiliations

    • Department of Obstetrics & Gynaecology, Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands
    • ,
  • C.G.J. Sweep

      Affiliations

    • Department of Chemical Endocrinology, Radboud University Nijmegen Medical Centre, Nijmegen, Geert Grooteplein 8, NL-6500 HB Nijmegen, The Netherlands
    • Corresponding Author InformationCorresponding author: Tel.: +31 243614279.

,Accepted 4 March 2009.

References 

  1. Challis JRG, Matthews SG, Gibb W, Lye SJ. Endocrine and paracrine regulation of birth at term and preterm. Endocrine Reviews. 2000;21:514–550
  2. McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human-pregnancy. Nature Medicine. 1995;1:460–463
  3. Erickson K, Thorsen P, Chrousos G, Grigoriadis DE, Khongsaly O, McGregor J, et al. Preterm birth: associated neuroendocrine, medical, and behavioral risk factors. Journal of Clinical Endocrinology and Metabolism. 2001;86:2544–2552
  4. McLean M, Smith R. Corticotrophin-releasing hormone and human parturition. Reproduction. 2001;121:493–501
  5. Smith R. Mechanisms of disease – parturition. New England Journal of Medicine. 2007;356:271–283
  6. Smith R, Mesiano S, McGrath S. Hormone trajectories leading to human birth. Regulatory Peptides. 2002;108:159–164
  7. Challis JRG. CRH, a placental clock and preterm labor. Nature Medicine. 1995;1:416
  8. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW, Dautzenberg FM. International union of pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacological Reviews. 2003;55:21–26
  9. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, et al. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:7570–7575
  10. Hsu SY, Hsueh AJW. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nature Medicine. 2001;7:605–611
  11. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, et al. Urocortin, a mammalian neuropeptide related to fish urotensin-I and to corticotropin-releasing factor. Nature. 1995;378:287–292
  12. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, et al. A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proceedings of the National Academy of Sciences of the United States of America. 2001;98:2843–2848
  13. Vale W, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science. 1981;213:1394–1397
  14. Watanabe F, Oki Y, Ozawa M, Masuzawa M, Iwabuchi M, Yoshimi T, et al. Urocortin in human placenta and maternal plasma. Peptides. 1999;20:205–209
  15. Glynn BP, Wolton A, Rodriguez-Linares B, Phaneuf S, Linton EA. Urocortin in pregnancy. American Journal of Obstetrics and Gynecology. 1998;179:533–539
  16. Petraglia F, Florio P, Benedetto C, Marozio L, Di Blasio AM, Ticconi C, et al. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. Journal of Clinical Endocrinology and Metabolism. 1999;84:1420–1423
  17. Li W, Challis JRG. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. Journal of Clinical Endocrinology and Metabolism. 2005;90:6569–6574
  18. Leitch IM, Boura ALA, Botti C, Read MA, Walters WAW, Smith R. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. Journal of Clinical Endocrinology and Metabolism. 1998;83:4510–4513
  19. Imperatore A, Florio P, Torres PB, Torricelli M, Galleri L, Toti P, et al. Urocortin 2 and urocortin 3 are expressed by the human placenta, deciduas, and fetal membranes. American Journal of Obstetrics and Gynecology. 2006;195:288–295
  20. Imperatore A, Rolfo A, Petraglia F, Challis JRG, Caniggia I. Urocortin 2 and 3 mRNA and protein expression are increased in preeclamptic placentae specimens. Reproductive Sciences. 2008;15(60):78A;317A
  21. Karteris E, Vatish M, Hillhouse EW, Grammatopoulos DK. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. Journal of Clinical Endocrinology and Metabolism. 2005;90:3680–3687
  22. Linton EA, Perkins AV, Hagan P, Poole S, Bristow AF, Tilders F, et al. Corticotropin-releasing hormone (CRH)-binding protein interference with CRH antibody-binding: implications for direct CRH immunoassay. Journal of Endocrinology. 1995;146:45–53
  23. Davis ME, Pemberton CJ, Yandle TG, Lainchbury JG, Rademaker MT, Nicholls MG, et al. Urocortin-1 infusion in normal humans. Journal of Clinical Endocrinology and Metabolism. 2004;89:1402–1409
  24. Chen A, Vaughan J, Vale WW. Glucocorticoids regulate the expression of the mouse urocortin II gene: A putative connection between the corticotropin-releasing factor receptor pathways. Journal of Molecular Endocrinology. 2003;17:1622–1639
  25. Li C, Vaughan J, Sawchenko PE, Vale WW. Urocortin III-immunoreactive projections in rat brain: partial overlap with sites of type 2 corticotrophin-releasing factor receptor expression. Journal of Neuroscience. 2002;22:991–1001
  26. Donoghuea JF, Leitch IM, Bouraa ALA, Waltersa WAW, Gilesc WB, Smith R, et al. Fetal placental vascular responses to corticotropin-releasing hormone in vitro: effects of variation in oxygen tension. Placenta. 2000;21:711–717
  27. Takahashi K, Totsune K, Murakami O, Saruta M, Nakabayashi M, Suzuki T, et al. Expression of urocortin III/stresscopin in human heart and kidney. Journal of Clinical Endocrinology and Metabolism. 2004;89:1897–1903
  28. Calogero AE, Bernardini R, Margioris AN, Bagdy G, Gallucci WT, Munson PJ, et al. Effects of serotonergic agonists and antagonists on corticotropin-releasing hormone-secretion by explanted rat hypothalami. Peptides. 1989;10:189–200
  29. Pepels PPLM, Pesman G, Korsten H, Wendelaar Bonga SE, Balm PHM. Corticotropin-releasing hormone (CRH) in the teleost fish Oreochromis mossambicus (tilapia): in vitro release and brain distribution determined by a novel radioimmunoassay. Peptides. 2002;23:1053–1062
  30. Pepels PPLM, van Helvoort H, Wendelaar Bonga SE, Balm PHM. Corticotropin-releasing hormone in the teleost stress response: rapid appearance of the peptide in plasma of tilapia (Oreochromis mossambicus). Journal of Endocrinology. 2004;180:425–438
  31. Bisseling TM, Wouterse AC, Steegers EA, Elving L, Russel FG, Smits P. Nitric oxide-mediated vascular tone in the fetal placental circulation of patients with type 1 diabetes mellitus. Placenta. 2003;24:974–978
  32. Florio P, Linton EA, Torricelli M, Faldini E, Reis FM, Imperatore A, et al. Prediction of preterm delivery based on maternal plasma urocortin. Journal of Clinical Endocrinology and Metabolism. 2007;
  33. Davis ME, Pemberton CJ, Yandle TG, Fisher SF, Lainchbury JG, Frampton CM, et al. Urocortin 2 infusion in human heart failure. European Heart Journal. 2007;28:2589–2597
  34. Besedin DV, Rudenskaia GN. Proline-specific endopeptidases. Russian Journal of Bioorganic Chemistry. 2003;29:1–17
  35. Shi SR, Guo J, Cote R, Young L, Hawes D, Shi Y, et al. Sensitivity and detection efficiency of a novel two-step detection system (PowerVision) for immunohistochemistry. Applied Immunohistochemistry & Molecular Morphology. 1999;7:201
  36. Jain V, Longo M, Ali M, Saade GR, Chwalisz K, Garfield RE. Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. Journal of the Society for Gynecologic Investigation. 2000;7:153–160
  37. Florio P, Calonaci G, Severi FM, Torricelli M, Bocchi C, Fiore G, et al. Reduced maternal plasma urocortin concentrations and impaired uterine artery blood flow at human mid pregnancy. Journal of the Society for Gynecologic Investigation. 2005;12:191–194
  38. Sun K, Smith R, Robinson PJ. Basal and KCl-stimulated corticotropin-releasing hormone-release from human placental syncytiotrophoblasts is inhibited by sodium-nitroprusside. Journal of Clinical Endocrinology and Metabolism. 1994;79:519–524
  39. Thomson M, Chan EC, Falconer J, Madsen G, Smith R. Secretion of corticotropin-releasing hormone by superfused human placental fragments. Gynecological Endocrinology. 1988;2:87–100

PII: S0143-4004(09)00093-9

doi: 10.1016/j.placenta.2009.03.008

Placenta
Volume 30, Issue 6 , Pages 483-490 , June 2009

Article Tools

* Image Usage & Resolution